Live News EQUITY L impact Jun 30, 2026, 05:14 PM UTC

Deutsche Bank Maintains Hold on Harmony Biosciences Hldgs, Raises Price Target to $36

Deutsche Bank analyst David Hoang maintains Harmony Biosciences Hldgs (NASDAQ: HRMY ) with a Hold and raises the price target from $30 to $36.

SQUAWKNEWS Updated Jun 30, 2026, 05:14 PM UTC

Deutsche Bank analyst David Hoang maintains Harmony Biosciences Hldgs (NASDAQ: HRMY ) with a Hold and raises the price target from $30 to $36.